Evidence map›Paper›PMID 39887448›Full record

ArticleJournal of pediatric gastroenterology and nutrition2025

Low TTG-IgA associated with isolated bulb pathology in pediatric celiac disease: Implications in a no-biopsy approach era.

Qing Yin Wang, Prévost Jantchou, Martha Dirks, Sébastien B Lavoie, Luc L Oligny, Dorothée Dal Soglio, Natacha Patey

Abstract read
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qing Yin WangDepartment of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-2633-6800
Prévost JantchouDepartment of Pediatrics, Unit of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Martha DirksDepartment of Pediatrics, Unit of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Sébastien B LavoieDepartment of Clinical Biochemistry, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Luc L OlignyDepartment of Pathology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Dorothée Dal SoglioDepartment of Pathology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Natacha PateyDepartment of Pathology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.

Funding

None
6 · The paper itself

Abstract

objectivesDuodenal involvement in celiac disease (CD) can be patchy, with a subset of patients demonstrating histopathological involvement limited to the bulb. This study evaluates whether bulb-restricted CD represents a distinct subgroup associated with lower titers of immunoglobulin A anti-tissue transglutaminase antibody (TTG-IgA) compared to distal duodenal CD in pediatric patients. Additionally, we assess the impact of a no-biopsy approach for pediatric CD with TTG-IgA ≥10 times the upper limit of normal (TTG-IgA ≥10× ULN) on the relative frequency of bulb-restricted CD among biopsied patients.

methodsIncident pediatric CD cases were identified retrospectively between 2017 and 2022. A no-biopsy approach for TTG-IgA ≥10× ULN was locally implemented in 2020. Serum TTG-IgA was categorized as negative, equivocal, positive TTG-IgA <10× ULN, and positive TTG-IgA≥ 10× ULN. Biopsies were classified by Marsh score and site of involvement.

resultsOf the 405 cases included (mean age = 9.6 years, female-to-male ratio = 2.1:1), bulb-restricted CD was present in 7.4%. TTG-IgA was negative or equivocal in 60.0% of bulb-restricted CD, compared to 5.3% of distal duodenal CD (odds ratio [OR] = 26.6; 95% confidence interval [CI] = [11.1-63.3], p < 0.001). Notably, no bulb-restricted CD cases attained TTG-IgA ≥10× ULN, compared to 48.5% of distal duodenal CD. Following local implementation of the no-biopsy approach for TTG-IgA ≥10× ULN, the relative percentage of bulb-restricted CD significantly increased from 4.6% to 12.4% (OR = 2.9, 95% CI = [1.4-6.4], p = 0.004).

conclusionPediatric CD with isolated bulb pathology presents with lower serum TTG-IgA titers than cases with distal duodenal involvement. Implementation of the no-biopsy approach increased the relative proportion of bulb-limited CD, as these cases were not associated with TTG-IgA ≥10× ULN.

Indexed as

AutoantibodiesCeliac DiseaseDuodenumImmunoglobulin ATransglutaminasesAdolescentBiopsyChildChild, PreschoolFemaleHumansMaleRetrospective Studiesanti-transglutaminase autoantibodyAutoantibodiesImmunoglobulin ATransglutaminasesduodenal bulb biopsyendomysial antibodyserology histology discordancetissue transglutaminase

Identifiers

PMID39887448
PMCPMC11959106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.